Evidence map›Paper›PMID 29731790›Full record

ReviewIranian journal of pathology2018

Prevalence of Clinically Isolated Metallo-beta-lactamase-producing

Abdolmajid Ghasemian, Kobra Salimian Rizi, Hassan Rajabi Vardanjani, Farshad Nojoomi

Open access · greenAbstract readReview
In one paragraph

Review in Iranian journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Survey of various carbapenem-resistant mechanisms ofIranian journal of basic medical sciences · 2020
    Article
  5. Article
  6. β-lactamase-mediated resistance in MDR-Pseudomonas aeruginosa from Qatar.Antimicrobial resistance and infection control · 2020
    Article
  7. Article
  8. The effect ofIranian journal of microbiology · 2019
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Abdolmajid GhasemianMicrobiology Dept, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.
Kobra Salimian RiziDept. of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Hassan Rajabi VardanjaniResearcher of Shahrekord University of Medical Sciences, Shahrekored, Iran.
Farshad NojoomiMicrobiology Dept, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran.
Tarbiat Modares University · IRAja University of Medical Sciences · IRShahrekord University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectiveThe spread of carbapenem-resistant DATA EXTRACTION: A total of 43 studies were found out of which 36 were adopted. Data were collected from Google, Google Scholar, Science Direct, PubMed, Scopus, Embase, and Sciverse. The terms "

resultsAccording to the results of the current study, 36 surveys indicated that 55% of the clinically isolated

conclusionApproximately half of

Indexed as

CarbapenemsIranMetallo-Beta-LactamasePseudomonas aeruginosa

Identifiers

PMID29731790
PMCPMC5929383
OpenAlexW2785313328

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.